sMICA and sMICB in Blood Plasma from Prostate Cancer Patients

·        patient: Patient's ID.·        age: Patient's age at the time of sample collection, measured in years.·        time.to_diagnosis: Time difference between the day of sample collection and the day of cancer diagnosis, measured in days.·        time.to_biometry: Time difference between the day of sample collection and the closest day of biometry (measurements of weight and height), measured in days.·        weight: Patient's weight, measured in kg.·        height: Patient's height, measured in cm.·        bmi: Patient’s body mass index, measured in kg/m2.·        time.to_mts: Time difference between the day of sample collection and the detection of metastases, measured in days.·        time.to_event: Time difference between the day of sample collection and the day of the last recorded contact with patients, categorized as death or patient's censoring.·        stage_T: Cancer stage at the time of diagnosis (T value).·        stage_N: Cancer stage at the time of diagnosis (N value).·        stage_M: Cancer stage at the time of diagnosis (M value).·        gleason: Gleason score at the time of diagnosis.·        spread: Expected cancer spread at the time sample collection.·        mica: Concentration of sMICA in blood plasma, measured in ng/ml.·        micb: Concentration of sMICB in blood plasma, measured in ng/ml.·        surgery.X: History of surgical treatment, where X denotes the distant border of the time period that commenced at the preceding time point (in days).·        radio.X: History of radiotherapy, where X denotes the distant border of the time period that commenced at the preceding time point (in days).·        horm.ther.X: History of hormone therapy, where X denotes the distant border of the time period that commenced at the preceding time point (in days).